Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

20 Nov 2012 07:00

RNS Number : 5073R
BrainJuicer Group PLC
20 November 2012
 



 

 

 

Press Release 20 November 2012

 

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Trading update

 

Innovative, international online market researcher BrainJuicer Group PLC (AIM:BJU) today issues the following update on trading for the financial year ending 31 December, 2012.

 

Revenue for the ten months to the end of October was up 11% over the prior year. However, trading in the final months of 2012 is proving disappointing. In particular, the strong seasonal increase in revenue which the Company has traditionally experienced during the final two months of its financial year, is not occurring in 2012. Revenue during the final quarter is therefore likely to fall significantly below 2011 levels.

 

In our interim results announcement we highlighted the 12% increase in costs during the first half as the Company continued its pursuit of future growth - strengthening its teams, broadening its geographical coverage, building its infrastructure and investing in product innovation. The rate of cost increase during the second half so far has been similar to that seen in the first half.

 

Pre-tax profits for the full year are therefore now expected to be substantially below the £2.8m achieved in 2011. The full year outturn will as always be heavily influenced by the Company's performance in December, and a further update will be issued during the early weeks of 2013.

 

BrainJuicer's financial position remains strong. At the end of October the Company's cash balance was £3.16m. BrainJuicer has no debt.

 

In terms of geography, our recently established businesses in China and Brazil are both delivering growth ahead of our expectations, and Switzerland is having another good year. Profitability in 2012 has been, to varying degrees, disappointing in the UK, Germany and the US, but the Board is confident that these businesses will return to profitable growth. Pending a pick up in revenue growth the Company is curtailing net new recruitment in these markets.

 

The current shortfall in revenue reflects primarily a decline in sales of our more traditional "Twist" products. Crucially, revenue from our innovative, added value "Juicy" products has continued to grow strongly. For the first 10 months of 2012 sales of Juicy products grew by 39%, compared with 22% decline in revenue for Twist products.

 

Perhaps most importantly, we remain convinced of our long term growth potential on the basis of BrainJuicer's approach to market research and the direction the industry is moving in. Traditional assumptions about how people make decisions are being undermined by a growing body of evidence in psychology, neuroscience, sociology and behavioural economics. Research is changing as a result, and BrainJuicer's evolving portfolio of Juicy products is at the forefront of this trend. The pace of change is slower than we would ideally like, but we believe that the barriers will continue to come down as the weight of data and proof continue to validate products such as ours.

 

The Company can be found at www.brainjuicer.com.

 

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUKAKRUWAAAAA
Date   Source Headline
1st May 20264:30 pmRNSHolding(s) in Company
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
21st Apr 20267:00 amRNSQ4 and Full Year Trading Update
9th Apr 20267:00 amRNS-RLaunch of next evolution of Test Your Ad platform
30th Mar 20264:30 pmRNSHolding(s) in Company
30th Mar 20263:30 pmRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTrading Update
16th Mar 20267:00 amRNSTrading Update
5th Mar 20263:15 pmRNSDirector/PDMR Shareholding
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20264:06 pmRNSBoard Change
2nd Mar 20261:39 pmRNSShareholder update & PDMR Dealing
2nd Mar 20267:00 amRNSDirectorate change
30th Jan 20261:00 pmRNSBoard Committee and Change of Role Update
20th Jan 20267:00 amRNSTrading Update
12th Jan 20264:45 pmRNSAppointment of Joint Corporate Broker
2nd Dec 20257:00 amRNSInterim Results
20th Nov 202511:45 amRNSHolding(s) in Company
24th Oct 20253:28 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSTrading Update
14th Oct 20259:16 amRNSCapital Markets Day
6th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSDirector/PDMR Shareholding - replacement
29th Sep 20255:48 pmRNSDirector/PDMR Shareholding
29th Sep 20251:27 pmRNSHolding(s) in Company
26th Sep 20252:29 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 20253:01 pmRNSResult of AGM
23rd Sep 20257:00 amRNSTrading Update
15th Sep 20251:00 pmRNSDirector/PDMR Shareholding
27th Aug 20254:51 pmRNSNotice of AGM
8th Aug 20254:35 pmRNSDirector/PDMR Shareholding
9th Jul 20257:00 amRNSDirector Role Change
9th Jul 20257:00 amRNSFinal Results
9th Jul 20257:00 amRNSTrading Update
4th Jul 202511:45 amRNSHolding(s) in Company
4th Jul 20257:00 amRNSHolding(s) in Company
16th Jun 20251:30 pmRNSHolding(s) in Company
14th May 20257:00 amRNSEstablishment of New Long-Term Incentive Plan
24th Apr 20251:53 pmRNSHolding(s) in Company
23rd Apr 20257:00 amRNSTrading Statement
23rd Jan 20257:00 amRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Update
8th Jan 202510:15 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSInterim Results
28th Nov 20247:00 amRNSInterim Results Presentation
21st Nov 20243:31 pmRNSHolding(s) in Company
28th Oct 202410:15 amRNSDirector/PDMR Shareholding
23rd Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.